Franklin Genomic Competition
| HELX Etf | USD 29.53 0.29 0.99% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Franklin Genomic competition on your existing holdings.
Franklin |
Franklin Genomic Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Franklin Genomic and its competitors represents the degree of relationship between the price movements of corresponding etfs. A correlation of about +1.0 implies that the price of Franklin and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Franklin Genomic Adv does not affect the price movement of the other competitor.
| -0.48 | 0.68 | 0.67 | 0.63 | EBIZ | ||
| -0.48 | -0.63 | -0.71 | -0.41 | GNOM | ||
| 0.68 | -0.63 | 0.97 | 0.89 | CLOU | ||
| 0.67 | -0.71 | 0.97 | 0.86 | FINX | ||
| 0.63 | -0.41 | 0.89 | 0.86 | BUG | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Franklin Genomic Constituents Risk-Adjusted Indicators
There is a big difference between Franklin Etf performing well and Franklin Genomic ETF doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Franklin Genomic's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EBIZ | 1.01 | 0.13 | 0.10 | 0.24 | 1.01 | 2.31 | 5.76 | |||
| GNOM | 1.28 | (0.34) | 0.00 | (0.19) | 0.00 | 1.85 | 8.48 | |||
| CLOU | 0.91 | 0.14 | 0.13 | 0.21 | 0.83 | 2.34 | 5.33 | |||
| FINX | 1.05 | 0.19 | 0.21 | 0.22 | 0.74 | 2.50 | 6.23 | |||
| BUG | 0.88 | (0.02) | 0.00 | 0.07 | 1.10 | 1.77 | 5.80 |
Franklin Genomic Competitive Analysis
The better you understand Franklin Genomic competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Franklin Genomic's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Franklin Genomic's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Franklin Genomic Competition Performance Charts
Five steps to successful analysis of Franklin Genomic Competition
Franklin Genomic's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Franklin Genomic Adv in relation to its competition. Franklin Genomic's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Franklin Genomic in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Franklin Genomic's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Franklin Genomic Adv, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Franklin Genomic position
In addition to having Franklin Genomic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Video Games Thematic Idea Now
Video Games
Companies that are involved in the building and marketing of video games or gaming software. The Video Games theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Video Games Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Franklin Genomic Correlation with its peers. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
The market value of Franklin Genomic Adv is measured differently than its book value, which is the value of Franklin that is recorded on the company's balance sheet. Investors also form their own opinion of Franklin Genomic's value that differs from its market value or its book value, called intrinsic value, which is Franklin Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Franklin Genomic's market value can be influenced by many factors that don't directly affect Franklin Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Franklin Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.